Cambridge Massachusetts based Bilayer Therapeutics is raising $3,600,000.00 in New Equity Investment.
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Bilayer Therapeutics is raising $3,600,000.00 in new funding. Sources indicate as part of senior management President, Thomas Collet played a key role…